SCHEMBL2659157

SCHEMBL2659157

CN(C)C(=O)c1nccc(Br)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.35
▸ LMNA P02545 2/20 0.35
▸ RIPK1 Q13546 2/20 0.35
▸ CYP1A2 P05177 5/20 0.34
▸ CYP3A4 P08684 4/20 0.34
▸ CYP2C19 P33261 4/20 0.34
▸ MAPK1 P28482 3/20 0.34
▸ CYP2D6 P10635 3/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ APEX1 P27695 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ USP2 O75604 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ DBF4 Q9UBU7 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ SMN1; SMN2 Q16637 5/20 0.32
▸ HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38660994 0.79 ALOX15 (0.41) ALDH1A1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL1670929 0.79 ALOX15 (0.41) ALDH1A1LMNACYP1A2CYP3A4CYP2C19
SCHEMBL18824676 0.78 ALDH1A1 (0.40) ALDH1A1LMNARIPK1CYP1A2CYP3A4
SCHEMBL1720706 0.76 KMO (0.49) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10718871 0.75 CSNK2A1 (0.36) ALDH1A1KMT2AKDM4ESMN1; SMN2TSHR
SCHEMBL27956903 0.75 KMO (0.36) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL2762628 0.74 KDM4E (0.40) ALDH1A1CYP1A2MAPK1ALOX15KMT2A
SCHEMBL9987095 0.73 P2RX7 (0.43) ALDH1A1LMNARIPK1HSD17B10KMT2A
Lithium Ion SCHEMBL31704998 0.73 CA1 (0.34) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL24921781 0.71 SYK (0.35) ALDH1A1CYP1A2CYP3A4CYP2C19MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010520-A1 FUSED PHENYL AMIDO HETEROCYCLIC COMPOUNDS FOR THE PREVENTION AND TREATMENT OF GLUCOKINASE-MEDIATED DISEASES Pfizer Products Incorporated (US) 2009-01-07 — — EP disclosed
WO-2007122482-A1 FUSED PHENYL AMIDO HETEROCYCLIC COMPOUNDS FOR THE PREVENTION AND TREATMENT OF GLUCOKINASE-MEDIATED DISEASES PFIZER PRODUCTS INC. (US) 2007-11-01 — — WO disclosed
Send feedback